STOCK TITAN

Balyasny group discloses 376,573 Rallybio shares (NASDAQ: RLYB)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Rallybio Corp ownership disclosure: reporting persons from Balyasny report beneficial ownership of 376,573 shares of Rallybio common stock, representing approximately 7.12% of the class based on 5,289,675 shares outstanding as of March 6, 2026. The shares are held directly by Atlas Diversified Master Fund, Ltd. (ADMF); Balyasny entities and Dmitry Balyasny state they may be deemed to beneficially own the shares by virtue of their management and GP/member roles. The principal business address for the reporting persons is 444 West Lake Street, Chicago, IL.

Positive

  • None.

Negative

  • None.

Insights

Large hedge fund affiliate holds roughly 7.12% of Rallybio.

Balyasny Asset Management and affiliated entities report beneficial ownership of 376,573 shares, equal to 7.12% of the 5,289,675 shares outstanding cited as of March 6, 2026. The shares are held by ADMF, of which BAM is the investment manager.

Filing shows typical ownership structure: manager, GP, holding entities, and the individual managing member. Subsequent filings could disclose changes in position or voting arrangements, but timing and any trading intentions are not stated in the excerpt.

Disclosure clarifies voting and dispositive powers across related entities.

The statement attributes sole voting and dispositive power over the 376,573 shares to the reporting entities, and explains the chain: BAM (investment manager) → BAM GP (general partner) → BAM Holdings → Dames → Mr. Balyasny.

This is a standard Schedule 13G ownership filing that documents beneficial ownership and control paths; it does not state any transaction activity or trading intent.

Shares held by ADMF 376,573 shares held directly by Atlas Diversified Master Fund, Ltd.
Percent of class 7.12% based on 5,289,675 shares outstanding as of March 6, 2026
Shares outstanding (base) 5,289,675 shares outstanding as of March 6, 2026 (source: issuer 10-K cited in filing)
Schedule 13G regulatory
"This statement is being filed by (1) Balyasny Asset Management L.P."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership regulatory
"may be deemed to beneficially own such Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Dispositive Power legal
"Sole Dispositive Power 376,573.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.





75120L209

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Balyasny Asset Management L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:05/11/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:05/11/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:05/11/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:05/11/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:05/11/2026

FAQ

What stake did Balyasny report in Rallybio (RLYB)?

Balyasny entities reported beneficial ownership of 376,573 shares, approximately 7.12%. The percentage is calculated using 5,289,675 shares outstanding as of March 6, 2026, per the filing.

Who legally holds the 376,573 Rallybio shares reported?

The shares are held directly by Atlas Diversified Master Fund, Ltd. (ADMF). Balyasny entities state they may be deemed beneficial owners due to management and GP/member roles over ADMF.

Do the filers state voting or dispositive power over the shares?

Yes. The filing states the reporting persons have sole voting and sole dispositive power over the 376,573 shares, as reflected in the ownership table in the statement.

Does the Schedule 13G show any trades or intentions to trade?

No. The filing documents beneficial ownership and control relationships; it does not disclose any purchase, sale, or trading intentions or timing in the provided excerpt.